
Donald Trump’s drug tariff spares generics, but India braces for fallout
The Hindu
U.S. President Donald Trump announces 100% tariff on branded pharmaceutical imports, pushing for U.S. manufacturing, impacting India's $20 billion industry.
More Related News













